Hogan Lovells International LLP

Leveraging its lawyers’ experience as government officials in regulatory and policy agencies, Hogan Lovells International LLP's Greater China life sciences practice is consistently sought out to for complex regulatory issues. The team advises at all stages of life sciences products, from initial clinical trials to off-patent strategy, business development and defence-side litigation The team also advises on new technology-driven areas, such as digital health, AI, gene therapy and regenerative medicine. On the mainland, Lu Zhou advises life sciences and healthcare clients on cross-border transactions; and Calvin Ding represents companies (and their board committees) in relation to corruption, conflicts of interest, trade compliance and cybersecurity incidents. Jessie Xie's practice covers regulatory work and commercial contracts in the pharmaceutical, medical devices, healthcare, food, and cosmetics sectors.